Mostrar el registro sencillo del ítem

dc.contributor.author
Whittaker, Danielle E.  
dc.contributor.author
Riegman, Kimberley L. H.  
dc.contributor.author
Kasah, Sahrunizam  
dc.contributor.author
Mohan, Conor  
dc.contributor.author
Yu, Tian  
dc.contributor.author
Sala, Blanca Pijuan  
dc.contributor.author
Hebaishi, Husam  
dc.contributor.author
Caruso, Angela  
dc.contributor.author
Marques, Ana Claudia  
dc.contributor.author
Michetti, Caterina  
dc.contributor.author
Sanz Smachetti, María Eugenia  
dc.contributor.author
Shah, Apar  
dc.contributor.author
Sabbioni, Mara  
dc.contributor.author
Kulhanci, Omer  
dc.contributor.author
Tee, Wee-Wei  
dc.contributor.author
Reinberg, Danny  
dc.contributor.author
Scattoni, Maria Luisa  
dc.contributor.author
Volk, Holger  
dc.contributor.author
McGonnell, Imelda  
dc.contributor.author
Wardle, Fiona C.  
dc.contributor.author
Fernandez, Cathy  
dc.contributor.author
Basson, Albert  
dc.date.available
2017-07-10T15:06:15Z  
dc.date.issued
2017-03-01  
dc.identifier.citation
Whittaker, Danielle E.; Riegman, Kimberley L. H.; Kasah, Sahrunizam; Mohan, Conor; Yu, Tian; et al.; The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression; Amer Soc Clinical Investigation Inc; Journal Of Clinical Investigation; 127; 3; 1-3-2017; 874-887  
dc.identifier.issn
0021-9738  
dc.identifier.uri
http://hdl.handle.net/11336/19973  
dc.description.abstract
The mechanisms underlying the neurodevelopmental deficits associated with CHARGE syndrome, which include cerebellar hypoplasia, developmental delay, coordination problems, and autistic features, have not been identified. CHARGE syndrome has been associated with mutations in the gene encoding the ATP-dependent chromatin remodeler CHD7. CHD7 is expressed in neural stem and progenitor cells, but its role in neurogenesis during brain development remains unknown. Here we have shown that deletion of Chd7 from cerebellar granule cell progenitors (GCps) results in reduced GCp proliferation, cerebellar hypoplasia, developmental delay, and motor deficits in mice. Genome-wide expression profiling revealed downregulated expression of the gene encoding the glycoprotein reelin (Reln) in Chd7-deficient GCps. Recessive RELN mutations have been associated with severe cerebellar hypoplasia in humans. We found molecular and genetic evidence that reductions in Reln expression contribute to GCp proliferative defects and cerebellar hypoplasia in GCp-specific Chd7 mouse mutants. Finally, we showed that CHD7 is necessary for maintaining an open, accessible chromatin state at the Reln locus. Taken together, this study shows that Reln gene expression is regulated by chromatin remodeling, identifies CHD7 as a previously unrecognized upstream regulator of Reln, and provides direct in vivo evidence that a mammalian CHD protein can control brain development by modulating chromatin accessibility in neuronal progenitors.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Amer Soc Clinical Investigation Inc  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Chd7  
dc.subject
Cerebellar Development  
dc.subject
Reelin Expresion  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-07-10T13:11:27Z  
dc.journal.volume
127  
dc.journal.number
3  
dc.journal.pagination
874-887  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Ann Arbor  
dc.description.fil
Fil: Whittaker, Danielle E.. Royal Veterinary College University Of London; . King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Riegman, Kimberley L. H.. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Kasah, Sahrunizam. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Mohan, Conor. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Yu, Tian. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Sala, Blanca Pijuan. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Hebaishi, Husam. University College London; Estados Unidos  
dc.description.fil
Fil: Caruso, Angela. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia  
dc.description.fil
Fil: Marques, Ana Claudia. University of Oxford. Department of Physiology, Anatomy and Genetics; Reino Unido  
dc.description.fil
Fil: Michetti, Caterina. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia  
dc.description.fil
Fil: Sanz Smachetti, María Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones En Biodiversidad y Biotecnología; Argentina. Fundación para Investigaciones Biológicas Aplicadas; Argentina  
dc.description.fil
Fil: Shah, Apar. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.description.fil
Fil: Sabbioni, Mara. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia  
dc.description.fil
Fil: Kulhanci, Omer. King’s College London, London, United Kingdom. Institute of Psychiatry, Psychology & Neuroscience. MRC Social, Genetic & Developmental Psychiatry Centre; Reino Unido  
dc.description.fil
Fil: Tee, Wee-Wei. New York University School of Medicine. Department of Molecular Pharmacology and Biochemistry. Howard Hughes Medical Institute; Estados Unidos  
dc.description.fil
Fil: Reinberg, Danny. New York University School of Medicine. Department of Molecular Pharmacology and Biochemistry. Howard Hughes Medical Institute; Estados Unidos  
dc.description.fil
Fil: Scattoni, Maria Luisa. Istituto Superiore di Sanità. Department of Cell Biology and Neuroscience. Neurotoxicology and Neuroendocrinology Section; Italia  
dc.description.fil
Fil: Volk, Holger. Royal Veterinary College University Of London; Reino Unido  
dc.description.fil
Fil: McGonnell, Imelda. Royal Veterinary College University Of London; Reino Unido  
dc.description.fil
Fil: Wardle, Fiona C.. King’s College London. Randall Division; Reino Unido  
dc.description.fil
Fil: Fernandez, Cathy. King’s College London, London, United Kingdom. Psychology & Neuroscience; Reino Unido  
dc.description.fil
Fil: Basson, Albert. King’s College London. Department of Craniofacial Development and Stem Cell Biology. Guy’s Hospital Tower Wing; Reino Unido  
dc.journal.title
Journal Of Clinical Investigation  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1172/JCI83408  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.jci.org/articles/view/83408